Other languages Twist Bioscience Corporation

Equities

TWST

US90184D1000

Market Closed - Nasdaq Other stock markets 04:00:06 2024-04-23 pm EDT			5-day change	1st Jan Change
31.5 ^USD	+6.96%		+10.10%	-14.54%

Mar. 28	Twist Bioscience Corporation Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	CI
Mar. 12	Transcript : Twist Bioscience Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 07:30 AM

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Twist Bioscience Corporation Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	Mar. 28
Twist Bioscience Corporation Launches IVDR-Compliant Precision Dx Products for Whole Exome Sequencing	Mar. 05
Twist Bioscience Announces Partnership With Element Biosciences, Launches Liquid Biopsy Kit	Feb. 06
Twist Bioscience Corporation and Element Biosciences, Inc. Announce Collaboration to Develop Twist for Element, Exome 2.0 Plus Comprehensive Exome Spike-In Workflow for Element?s AVITI System	Feb. 06
Twist Bioscience Corporation Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications	Feb. 06
Twist Bioscience Corporation Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT	Feb. 05
Sector Update: Health Care Stocks Steady Premarket Friday	Feb. 02
Twist Bioscience's Fiscal Q1 Net Loss Widens, Revenue Rises; Fiscal 2024 Revenue Guidance Lifted	Feb. 02
Twist Bioscience Corporation Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024	Feb. 02
Twist Bioscience Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 02
Twist Bioscience Corporation Updates Earnings Guidance for the Full Fiscal Year 2024	Feb. 02
Twist Bioscience Corporation Expands Express Genes Rapid Synthesis Service	Jan. 24
Twist Bioscience Names Adam Laponis Chief Financial Officer	Jan. 05
Twist Bioscience Corporation Appoints Adam Laponis as Principal Financial Officer, Effective January 8, 2024	Jan. 05
Sector Update: Health Care Stocks Advance Premarket Friday	Nov. 17
Sector Update: Health Care	Nov. 17
Twist Bioscience's Fiscal Q4 Net Loss Narrows, Revenue Rises	Nov. 17
Twist Bioscience Corporation Provides Revenue Guidance for the First Quarter, Fourth Quarter and Full Fiscal Year of 2024	Nov. 17
Twist Bioscience Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	Nov. 17
Twist Bioscience Corporation Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Nov. 17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Twist Bioscience Corporation

Equities

TWST

US90184D1000

Other languages

Filters